Piper Jaffray Upgrades Horizon Pharma To Overweight
March 31, 2015 at 09:29 AM EDT
Analysts at Piper Jaffray upgraded Horizon Pharma plc (NASDAQ: HZNP) from Neutral to Overweight. The price target for Horizon Pharma ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.